{
  "id" : "grade_clinical_25704",
  "algorithm" : "eod_public",
  "version" : "1.2",
  "name" : "Grade Clinical",
  "title" : "Grade Clinical",
  "notes" : "**Note 1:** Clinical grade must not be blank.\n\n**Note 2:** Assign the highest grade from the primary tumor assessed during the clinical time frame. \n\n**Note 3:** Codes L and H take priority over A-D. \n\n**Note 4:** Code 9 when\n* Grade from primary site is not documented\n* Clinical workup is not done (for example, cancer is an incidental finding during surgery for another condition)\n* Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available\n\n**Note 5:** If there is only one grade available and it cannot be determined if it is clinical, pathological, or after neo-adjuvant therapy, assign as a clinical grade and code unknown (9) for pathological grade, and blank for post-therapy grade.",
  "last_modified" : "2018-05-09T15:33:21.295Z",
  "definition" : [ {
    "key" : "grade_clin",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "L", "LG: Low grade: round monomorphic nuclei with only mild to moderate nuclear size variation, indistinct nucleoli, and chromatin characteristics resembling those of normal parathyroid or of adenoma" ], [ "H", "HG: High grade: more pleomorphism, with a nuclear size variation greater than 4:1; prominent nuclear membrane irregularities; chromatin alterations, including hyperchromasia or margination of chromatin; and prominent nucleoli. High-grade tumors show several discrete confluent areas with nuclear changes" ], [ "A", "Well differentiated" ], [ "B", "Moderately differentiated" ], [ "C", "Poorly differentiated" ], [ "D", "Undifferentiated, anaplastic" ], [ "9", "Grade cannot be assessed (GX); Unknown" ] ]
}